All In Biotech

Drug Trial Radar · NCT07486934

Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1

A Phase 3, Randomized, Double-Blind, 48-Week Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of DYNE-101 Administered to Participants With Myotonic Dystrophy Type 1

Last checked: Nov 20, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 150 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

150

Planned (sponsor's estimate)

Start

May 14, 2026

Primary completion

Jul 2028

Study completion Jan 2029

Sponsor

Lead sponsor
Dyne TherapeuticsIndustry
Sponsor type
Industry
First posted
Mar 23, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 16 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to assess the efficacy, safety, and tolerability of zeleciment basivarsen (DYNE-101) for the treatment of myotonic dystrophy 1 (DM1).

Conditions

  • Myotonic Dystrophy Type 1 (DM1)
  • DM1
  • Myotonic Dystrophy
  • Steinert Disease
  • Steinert

Interventions

  • zeleciment basivarsen (DYNE-101)Drug

    Administered by IV infusion

  • PlaceboDrug

    Administered by IV infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. 5 Times Sit-To-Stand (5×STS) TimeTime frame: Baseline, Week 49

Locations

45 sites in 12 countries. Site status is shown where the registry gives one.

  • UCSD - Altman Clinical and Translational Research Institute

    La Jolla, California · Recruiting

  • UCLA Medical Center (Department of Neurology)

    Los Angeles, California · Recruiting

  • Stanford Neuroscience Health Center

    Palo Alto, California · Recruiting

  • UF Health: University of Florida Clinical Research Center

    Gainesville, Florida · Recruiting

  • Rare Disease Research, LLC

    Atlanta, Georgia · Recruiting

  • IU Health Neuroscience Center

    Indianapolis, Indiana · Recruiting

  • Kennedy Krieger Institute

    Baltimore, Maryland · Recruiting

  • Roy Blunt NextGen Precision Health Institute

    Columbia, Missouri · Recruiting

  • University of Rochester Medical Center

    Rochester, New York · Recruiting

  • Rare Disease Research, LLC

    Hillsborough, North Carolina · Recruiting

  • Houston Methodist Neurological Institute

    Houston, Texas · Recruiting

  • The University of Texas Health Science Center at San Antonio

    San Antonio, Texas · Recruiting

  • University of Utah Clinical Neurosciences Center

    Salt Lake City, Utah · Recruiting

  • Virginia Commonwealth University - Biotech One

    Richmond, Virginia · Recruiting

  • St Vincent's Hospital, Melbourne

    Fitzroy, Victoria, Australia · Recruiting

  • UZA

    Edegem, Belgium · Recruiting

  • UZ Leuven

    Leuven, Belgium · Recruiting

  • Aarhus University Hospital, Department of Neurology

    Aarhus, Denmark · Recruiting

  • Rigshospitalet, (Neuromuscular Clinic and Research Unit, Department 8077)

    Copenhagen, Denmark · Recruiting

  • AP-HP, Hôpital Raymond-Poincaré

    Garches, France · Recruiting

  • CHU Marseille - Hôpital de la Timone (APHM)

    Marseille, France · Recruiting

  • CHU de Nantes - Hôtel-Dieu

    Nantes, France · Recruiting

  • Pitié-Salpêtrière Hospital

    Paris, France · Recruiting

  • CHU de Toulouse - Hôpital Pierre-Paul Riquet

    Toulouse, France · Recruiting

  • LMU Klinikum der Universität München Neurologische Klinik und Poliklinik Friedrich-Baur-Institut Campus Innenstadt

    Munich, Bavaria, Germany · Recruiting

  • Universitätsmedizin Göttingen

    Göttingen, Lower Saxony, Germany · Recruiting

  • Universitätsklinikum Bonn AöR Zentrum für Neurologie Klinik für Neuroimmunologie und Neuromuskuläre Erkrankungen

    Bonn, North Rhine-Westphalia, Germany · Recruiting

  • Charité Universitätsmedizin Berlin Campus-Buch Muscle Research Unit

    Berlin, State of Berlin, Germany · Recruiting

  • Centro Clinico Nemo Brescia, Fondazione Serena ETS

    Gussago, Brescia, Italy · Recruiting

  • Centro Clinico Nemo Milano, Fondazione Serena ETS

    Milan, Milano, Italy · Recruiting

  • Fondazione Policlinico Universitario A. Gemelli IRCCS - Department of Women's, Child and Public Health Sciences - UOC Neuropsichiatria Infantile

    Roma, Roma, Italy · Recruiting

  • Azienda Ospedaliero-Universitaria Sant'Andrea - UOC Neurologia

    Roma, Roma, Italy · Recruiting

  • Niigata National Hospital, National Hospital Organization

    Kashiwazaki, Niigata, Japan · Recruiting

  • The University of Osaka Hospital

    Suita-shi, Osaka, Japan · Recruiting

  • National Hospital Organization Osaka Toneyama Medical Center

    Toyonaka-Shi, Osaka, Japan · Recruiting

  • National Center Hospital, National Center of Neurology and Psychiatry (NCNP)

    Kodaira, Tokyo, Japan · Recruiting

  • Yamaguchi University Hospital

    Ube-Shi, Yamaguchi, Japan · Recruiting

  • University of Maastricht

    Maastricht, Netherlands · Recruiting

  • Radboud University Medical Center

    Nijmegen, Netherlands · Recruiting

  • University of Auckland

    Auckland, Auckland, New Zealand · Recruiting

Showing 40 of 45 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.